SEC Form 4 · accession 0001651844-16-000015
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Apr 11, 2016
Accepted (ET)
Apr 15, 2016 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 11, 2016 | P | 4,500 | $2.53 | A | 2,722,550 | D | |
| Common Stock | Apr 11, 2016 | P | 4,500 | $2.49 | A | 2,727,050 | D | |
| Common Stock | Apr 12, 2016 | P | 4,500 | $2.45 | A | 2,731,550 | D | |
| Common Stock | Apr 12, 2016 | P | 3,000 | $2.45 | A | 2,734,550 | D | |
| Common Stock | Apr 12, 2016 | P | 3,000 | $2.40 | A | 2,737,550 | D | |
| Common Stock | Apr 13, 2016 | P | 5,000 | $2.32 | A | 2,742,550 | D | |
| Common Stock | Apr 13, 2016 | P | 5,000 | $2.19 | A | 2,747,550 | D | |
| Common Stock | Apr 15, 2016 | P | 3,500 | $2.39 | A | 2,751,050 | D | |
| Common Stock | Apr 15, 2016 | P | 3,000 | $2.37 | A | 2,754,050 | D | |
| Common Stock | Apr 15, 2016 | P | 3,500 | $2.39 | A | 2,757,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.